Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Le Bail

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|December 15, 2015
Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsyChristophe Cassinotto, Jérome Boursier, Victor de Lédinghen, et al.
Annals of Hepatology|July 2, 2013
Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probeGrace Lai-Hung Wong, Julien Vergniol, Peter Lo, et al.
The Journal of Infectious Diseases|July 23, 2002
CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatmentElisabeth Legrand, Didier Neau, Tatiana Galperine, et al.
World Journal of Gastroenterology|December 5, 2006
Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective studyLaurent Castéra, Anne Pedeboscq, Marcia Rocha, et al.
Journal of Hepatology|May 7, 2016
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver diseaseJérôme Boursier, Julien Vergniol, Anne Guillet, et al.
Gut|January 20, 2019
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver diseaseVincent Wai-Sun Wong, Marie Irles, Grace Lai-Hung Wong, et al.
Journal of Hepatology|December 17, 2011
Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®Victor de Lédinghen, Vincent Wai-Sun Wong, Julien Vergniol, et al.
Hepatology (Baltimore, Md.)|January 27, 2010
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver diseaseVincent Wai-Sun Wong, Julien Vergniol, Grace Lai-Hung Wong, et al.
Hepatology (Baltimore, Md.)|June 25, 2017
Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding riskElodie Henriet, Aya Abou Hammoud, Jean-William Dupuy, et al.
Hepatology Communications|February 7, 2018
MicroRNA therapy inhibits hepatoblastoma growth <i>in vivo</i> by targeting β-catenin and Wnt signalingEmilie Indersie, Sarah Lesjean, Katarzyna B Hooks, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|December 15, 2015
Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsyChristophe Cassinotto, Jérome Boursier, Victor de Lédinghen, et al.
Annals of Hepatology|July 2, 2013
Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probeGrace Lai-Hung Wong, Julien Vergniol, Peter Lo, et al.
The Journal of Infectious Diseases|July 23, 2002
CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatmentElisabeth Legrand, Didier Neau, Tatiana Galperine, et al.
World Journal of Gastroenterology|December 5, 2006
Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective studyLaurent Castéra, Anne Pedeboscq, Marcia Rocha, et al.
Journal of Hepatology|May 7, 2016
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver diseaseJérôme Boursier, Julien Vergniol, Anne Guillet, et al.
Gut|January 20, 2019
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver diseaseVincent Wai-Sun Wong, Marie Irles, Grace Lai-Hung Wong, et al.
Journal of Hepatology|December 17, 2011
Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®Victor de Lédinghen, Vincent Wai-Sun Wong, Julien Vergniol, et al.
Hepatology (Baltimore, Md.)|January 27, 2010
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver diseaseVincent Wai-Sun Wong, Julien Vergniol, Grace Lai-Hung Wong, et al.
Hepatology (Baltimore, Md.)|June 25, 2017
Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding riskElodie Henriet, Aya Abou Hammoud, Jean-William Dupuy, et al.
Hepatology Communications|February 7, 2018
MicroRNA therapy inhibits hepatoblastoma growth <i>in vivo</i> by targeting β-catenin and Wnt signalingEmilie Indersie, Sarah Lesjean, Katarzyna B Hooks, et al.
Pageof 12